Fulgent Genetics Long Term Debt 2015-2025 | FLGT

Fulgent Genetics long term debt from 2015 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Fulgent Genetics Annual Long Term Debt
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
Fulgent Genetics Quarterly Long Term Debt
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30 $6
2021-06-30 $6
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.644B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.328B 59.20
Hims & Hers Health (HIMS) United States $12.250B 127.28
Tempus AI (TEM) United States $10.726B 0.00
IRhythm Technologies (IRTC) United States $4.629B 0.00
Inspire Medical Systems (INSP) United States $4.081B 63.76
Hinge Health (HNGE) United States $3.147B 0.00
Privia Health (PRVA) United States $2.800B 191.42
Enovis (ENOV) United States $1.753B 9.77
Schrodinger (SDGR) United States $1.680B 0.00
Clover Health Investments (CLOV) United States $1.578B 0.00
Phreesia (PHR) United States $1.534B 0.00
Omnicell (OMCL) United States $1.453B 25.64
Azenta (AZTA) United States $1.298B 60.34
10x Genomics (TXG) United States $1.122B 0.00
Claritev (CTEV) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.584B 0.00
Talkspace (TALK) United States $0.571B 170.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.357B 793.00
Outset Medical (OM) United States $0.344B 0.00
Health Catalyst (HCAT) United States $0.281B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
KORU Medical Systems (KRMD) United States $0.131B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.092B 3.50
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00